HMGB2 and melanoma: Loss of hmgb2 and hmgb2b markedly increased melanoma growth, with tumours growing almost 2-fold larger by 10 weeks (P = 0.0193; Fig. 5j–l) while also appearing less invasive than non-targeting controls (Fig. 5m).